Their responses, often defensive and minimal, underscore a significant level of accountability for the harm caused to users
B12 isn't a weight-loss medication
Seven electronic databases were searched: PubMed, Scopus, Web of Science, Embase, Cochrane Library, Google Scholar, and medRxiv
Subgroup analysis indicated that homozygous mutations were associated with more severe impairment of long-term weight loss than heterozygous mutations, which explains why bi-allelic MC4R mutation carriers have poorer long-term outcomes than heterozygous carriers
It is listed as a co-lyophilized combination of separately specified components, in the Peptide Blends & Multi-Component Formulations category
Aug 16 2021;11(8):e053019